Ignite Creation Date:
2025-12-24 @ 5:48 PM
Ignite Modification Date:
2026-01-04 @ 2:33 PM
Study NCT ID:
NCT06889168
Status:
RECRUITING
Last Update Posted:
2025-08-08
First Post:
2025-03-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)
Sponsor:
Columbia University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-03
Completion Date Type:
ESTIMATED
First Submit Date:
2025-03-15
First Submit QC Date:
None
Study First Post Date:
2025-03-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-05
Last Update Post Date:
2025-08-08
Last Update Post Date Type:
ACTUAL